North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
FDA warning letter issued 2022-11-18 · posted 2023-01-24
Letter details
- Company
- North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- Subject
- Compounding Pharmacy/Adulterated Drug Products
- Issuing office
- Division of Pharmaceutical Quality Operations II
- Letter issue date
- 2022-11-18
- Posted date
- 2023-01-24
- Case number
- 642792
- Closeout letter
- 03/20/2026
Read the full letter on fda.gov
FDA's public listing keeps roughly five years of letters; older ones roll off. Atlas preserves every letter it has ingested since September 2026 and refreshes the listing weekly. Verify enforcement matters against the primary source linked above.
Hear about the next one
Watch an issuing office from its directory page and new letters land in your change alerts. Elsewhere this data sells for hundreds of dollars per document; here it is part of the record.